Fifth Third Bancorp Buys 6,687 Shares of Corteva, Inc. $CTVA

Fifth Third Bancorp increased its position in shares of Corteva, Inc. (NYSE:CTVA) by 4.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 155,587 shares of the company’s stock after buying an additional 6,687 shares during the period. Fifth Third Bancorp’s holdings in Corteva were worth $10,522,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Activest Wealth Management lifted its position in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the last quarter. True Wealth Design LLC boosted its stake in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Total Investment Management Inc. purchased a new position in Corteva in the second quarter valued at $27,000. Curat Global LLC raised its holdings in Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares during the period. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in shares of Corteva during the 2nd quarter valued at approximately $29,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Trading Up 0.5%

Shares of Corteva stock opened at $75.40 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The business has a 50 day moving average price of $70.06 and a 200 day moving average price of $68.46. The company has a market capitalization of $50.71 billion, a P/E ratio of 47.72, a P/E/G ratio of 2.56 and a beta of 0.75.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on CTVA shares. CICC Research increased their target price on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. The Goldman Sachs Group reiterated a “buy” rating and set a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. Zacks Research upgraded Corteva from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 22nd. Wells Fargo & Company boosted their price objective on shares of Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $82.30.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.